HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Campylobacter jejuni enteritis and Guillain-Barré syndrome].

Abstract
Some patients developed Guillain-Barré syndrome after the administration of bovine brain ganglioside. Patients with Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis frequently have IgG antibody to GM1 ganglioside. Miller Fisher syndrome, a variant of Guillain-Barré syndrome, is associated with IgG antibody to GQ1b ganglioside. My colleagues and I showed the existence of molecular mimicry between GM1 and lipopolysaccharide of C. jejuni isolated from a patient with Guillain-Barré syndrome, and that between GQ1b and C. jejuni lipopolysaccharides from patients with Miller Fisher syndrome. The glycotope mimicry between infectious agents and gangliosides may function in the production of antiganglioside antibodies and the development of Guillain-Barré syndrome and Miller Fisher syndrome.
AuthorsN Yuki
JournalRinsho byori. The Japanese journal of clinical pathology (Rinsho Byori) Vol. 47 Issue 8 Pg. 713-8 (Aug 1999) ISSN: 0047-1860 [Print] Japan
PMID10511801 (Publication Type: Journal Article, Review)
Chemical References
  • Gangliosides
  • Lipopolysaccharides
Topics
  • Campylobacter Infections (immunology)
  • Campylobacter jejuni (immunology)
  • Enteritis (immunology)
  • Gangliosides (immunology)
  • Guillain-Barre Syndrome (immunology)
  • Humans
  • Lipopolysaccharides (immunology)
  • Miller Fisher Syndrome (immunology)
  • Molecular Mimicry

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: